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Abstract: In the present voxel-based morphometric study, we investigated whether the severity and duration of disease 
are associated with alterations in gray matter volume (GMV) in symptomatic Parkin mutation carriers (sPARKIN-MC) 
and patients with idiopathic Parkinson’s disease (iPD). Regression analyses revealed different negative correlations be-
tween GMV in cortical motor areas and the severity as well as the disease duration in sPARKIN-MC and iPD patients. 
SPARKIN-MC showed a less involvement of cortical motor areas, in particular in the supplementary motor area (SMA) 
than iPD patients. Specifically, in iPD patients, but not in sPARKIN-MC, there was a negative correlation between the 
SMA degeneration and the UPDRS-II item freezing. The different degeneration patterns may mirror diverse kinetics of 
the disease progress in these two groups of PD patients with different underlying etiologies. 
Keywords: Parkin mutation carriers, Parkinson’s disease, supplemetary motor area, voxel-based morphometry. 
INTRODUCTION 
  Although the origin of the disease currently remains un-
known in the majority of patients with idiopathic Parkinson’s 
disease (iPD), about 5% of all cases are associated with a 
mutation in a single gene. A monogenic cause is much more 
frequent among patients with early-onset parkinsonism (10-
20%), of which mutations in the Parkin gene are the most 
common known cause [1]. Although there is substantial 
clinical overlap, Parkin-associated PD tends to manifest ear-
lier, has a milder course and a better response to levodopa 
than iPD patients [2].  
  While some previous MR-based morphometric studies 
failed to show regional differences in cortical volume be-
tween iPD patients and controls [3], other morphometric 
studies found a reduction of gray matter volume (GMV) in 
frontal [3, 4], temporal [3-5] and parietal areas [4], hippo-
campus [5] and anterior cingulate cortex [5]. Here, we used 
voxel-based morphometry (VBM) to test for a linear rela-
tionship between clinical features of PD and regional GMV. 
Since we made the clinical observation that the symptomatic 
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Parkin mutation carriers (sPARKIN-MC) had less freezing 
problems than iPD patients, special emphasis was placed on 
the investigation of the pathoanatomical basis of this differ-
ential clinical manifestation.  
METHODS 
  We compared structural MR-images of 9 sPARKIN-MC, 
identified in large-scale genetic studies [6], (two females, 
mean age: 52.3 ± 3.8 years) and 14 iPD patients (eight fe-
males, mean age: 50.9 ± 1.1 years) with 24 age- and sex-
matched healthy controls (11 females, mean age: 52.1 ± 1.5 
years). The motor section of the Unified Parkinson’s Disease 
Rating Scale (UPDRS-III) and a standardized clinical psy-
chiatric examination including screening for dementia (Mini-
Mental State Examination [MMSE] were performed. Details 
of demographic and clinical findings have been published 
elsewhere [7]. None of the participants suffered from demen-
tia. All subjects and patients gave their informed written 
consent for participation in this study, which was approved 
by the local ethics committee in accordance with the ethical 
standards in the declaration of Helsinki. 
 T 1-weighted FLASH-3D MR-images (echo time [TE] = 
5ms; repetition time [TR] = 15ms; flip angle = 30°; voxel 
size 1x1x1 mm
3) were assessed on a 1.5 T scanner (Sym-
phony, Siemens, Erlangen, Germany). Morphometric analy-VBM in Genetic and Idiopathic PD  The Open Neuroimaging Journal, 2008, Volume 2    103 
ses were performed using SPM2 software (FIL, London, 
www.fil.ion.ucl.ac.uk/spm) and the modified VBM protocol. 
Details of the VBM procedure are described elsewhere [8]. 
  VBM employed a categorical comparison between pa-
tients and controls (ANOVA; GMV threshold: 0.25) as well 
as simple regression analyses with motor scores and disease 
duration as explanatory variables. We hypothesized that re-
gional changes in GMV would occur primarily in the sup-
plementary motor area (SMA), primary motor cortex (M1) 
and premotor cortex (PMC). Given our a-priori hypothesis, 
we applied a region-of-interest analysis for voxels within 
these primary and premotor areas using the WFU-PickAtlas 
(ANSIR, Wake Forest University) as anatomical reference. 
The statistical threshold was set at pFDR < 0.05 after correc-
tion for whole brain volume. For region-of-interest analysis, 
small volume correction (SVC) was applied using a spherical 
volume of 8 mm.  
RESULTS 
  While mean UPDRS-III scores were matched between 
groups (sPARKIN-MC = 22.0 ± 4.3; iPD patients = 22.7 ± 
3.3; t-test: p = 0.89), the item “freezing” in the UPDRS-II 
showed trend towards a difference: sPARKIN-MC reached a 
median of 0.50 (range: 0–1) and iPD patients of 1.00 (range: 
0–3; Wilcoxon-test p = 0.06). There was no difference in 
mean disease duration, defined as time from symptom onset, 
between groups (sPARKIN-MC = 14 ± 3.1 years vs. iPD 
patients = 12.1 ± 1.0 years; t-test: p = 0.49).  
  Voxel-by-voxel comparison of cortical GMV revealed no 
significant differences between sPARKIN-MC, iPD patients, 
and age- and sex-matched healthy controls. Within-group 
regression analysis showed an inverse linear relationship 
between total UPDRS-III scores and regional GMV in left 
SMA, left M1, right ventral PMC and bilateral dorsal PMC 
in iPD patients (Table 1). In sPARKIN-MC only the dorsal 
Table 1.  Coordinates and Gray Matter Values for Cortical Motor Areas in sPARKIN-MC and iPD Patients 
Region  Side  MNI Coordinates in mm  T-Value  Z-Score  pFDR (SVC) 
   x  y  z       
Regression analysis with UPDRSIII 
a) sPARKIN-MC 
SMA - - -  -  -  -  - 
dPMC R  22 -7  60  7.76  4.04  0.009 
dPMC L  -26  -12  61  6.38  3.70  0.015 
b) iPD patients       
SMA L  -3 4  60  4.59  3.42  0.048 
M1 L  -63  -6  27  4.35  3.31  0.021 
vPMC R  64 8  19  5.57  3.84  0.014 
dPMC R  31 10  63  4.96  3.59  0.031 
dPMC L  -63  -5  28  4.86  3.55  0.019 
Regression analysis with freezing score 
a) sPARKIN-MC           
SMA - - -  -  -  -  - 
b) iPD patients            
SMA L  -2 4  66  6.92  4.31  0.002 
SMA L  -6  24  61  5.06  3.63  0.023 
Regression analysis with disease duration 
a) sPARKIN-MC 
SMA - - -  -  -  -  - 
b) iPD patients       
SMA L  -18  -8  65  3.95  3.10  0.046 
M1 R  24  -28  63  4.92  3.58  0.031 
dPMC L  -45  -10  39  4.92  3.58  0.015 
dPMC: dorsal premotor cortex, vPMC: ventral premotor cortex M1: primary motor cortex, SMA: supplementary motor area. 104    The Open Neuroimaging Journal, 2008, Volume 2  Reetz et al. 
PMC showed a bilateral decrease in GMV with increasing 
UPDRS-III scores. When correlating the morphometric data 
with the clinicial UPDRS-II item which scores “freezing”, 
regression analysis revealed a linear GMV decrease with 
freezing in the left SMA (as well as a trend in the right 
SMA) in the iPD group (Table 1, Fig. 1) but not in the 
sPARKIN-MC group. When using mean disease duration as 
explanatory variable, a linear decrease in GMV with disease 
duration was found in left dorsal PMC, right M1 and left 
SMA, again only in iPD patients (Table 1).  
  The clinical regression analysis with the freezing item, 
obtained from the UPDRS-II revealed a decrease in GMV in 
the SMA in iPD patients (none in sPARKIN-MC). On the 
right side the negative correlation plot of the regression 
analysis between the freezing item (UPDRS-II) and the de-
crease in grey matter density in the SMA (x = -2. y = 4, z = 
66, Z = 4.31, pFDR = 0.002, R = 0.89) in iPD patients is 
displayed (for better visualisation a threshold p < 0.05 was 
used). 
DISCUSSION 
  Using whole-brain VBM, we found a gradual reduction 
in GMV in cortical motor areas that shows a linear relation 
to the severity of individual motor symptoms and duration of 
disease in iPD patients. This linear relationship between mo-
tor symptoms and cortical VBM was less pronounced in the 
sPARKIN-MC group, especially in the SMA. This may rep-
resent an anatomical correlate of the clinical observation that 
sPARKIN-MC have slower progression of disease and show 
less freezing problems than iPD patients [6]. 
 In  sPARKIN-MC, a linear decrease in GMV with the 
severity of motor symptoms was only significant in the dor-
sal PMC, and there was no clear relationship between GMV 
in motor cortical areas and disease duration. The weaker 
relationship between cortical GMV and clinical features of 
PD might indicate that cortical motor structures are less af-
fected by neurodegeneration in sPARKIN-MC than in iPD 
patients. A relative sparing of cortical motor areas might at 
least partially account for the slower and more symmetric 
onset of symptoms, the better response to L-Dopa and the 
generally favourable outcome in sPARKIN-MC [6]. 
  Only patients with iPD displayed a linear reduction in 
GMV with the severity of motor symptoms in the rostral 
SMA. They also had more freezing problems than sPARKIN-
MC, and showed a linear decrease in GMV in the SMA de-
pending on the individual freezing score. These observations 
tie in with current concepts of the role of the SMA in motor 
dysfunction in iPD, especially freezing. The SMA belongs to 
the mesial initiation motor system, whereas the lateral pre-
motor areas are part of the lateral integrative motor system 
[9]. A malfunction of the mesial motor areas in iPD patients 
have been reported in several electrophysiological and neu-
roimaging studies, and may constitute a functional correlate 
for the difficulties to initiate movements internally and to the 
clinically observed freezing problems in iPD patients. A de-
creased activity of the rostral SMA, anterior cingulate cortex, 
and lateral prefrontal cortex was found in iPD patients dur-
ing the execution of free chosen hand [10] or complex finger 
movements [11] as demonstrated by PET and functional 
MRI. Accordingly, electroencephalographic (EEG) studies 
showed a relative „deactivation“ of the fronto-central cortex 
in the preparation phase of finger movements [12] and a 
shortened period of pre-movement desynchronisation in the 
alpha- and beta-frequency bands [13] in iPD patients. These 
results have been interpreted as evidence for a deficient ac-
tivity of the SMA via the medial premotor basal ganglia loop 
in untreated iPD patients. 
  A correlation between the degeneration of the lateral 
PMC and the severity of motor symptoms was found in both 
groups of patients. The dorsal PMC is supposed to play a 
crucial role in the preparation of externally triggered move-
ments (e.g. through sensory stimuli) [14], and therefore it 
seems to be predominantly active during the planning and 
execution of sensory guided movements [15]. Event related 
EEG studies showed a movement related increase in activity 
of the dorsal PMC in PD patients [12]. Also in PET and 
functional MRI studies, an increased activity of the dorsal 















Fig. (1). Clinical correlation between the UPDRS-II freezing item in iPD patients. VBM in Genetic and Idiopathic PD  The Open Neuroimaging Journal, 2008, Volume 2    105 
[16], complex finger movements [11] and free choice finger 
movements. The increased activity in the dorsal PMC has 
been interpreted as a sign for a compensatory reorganization 
of the motor system with stronger use of the cerebello-
parieto-premotor loops as a reaction to the deficient function 
of the medial PMC and the basal ganglia loop [16]. The re-
sults of the present morphometric study raise the possibility 
that the capacity to compensate in this lateral premotor loop 
may fade during the course of disease with increasing sever-
ity of symptoms. This hypothesis remains to be addressed in 
future studies.  
CONCLUSIONS 
  The present results show that MRI morphometry in con-
junction with genetic and clinical characterization of patients 
provides a powerful tool to achieve a better understanding of 
the morphometric correlates and regional function-structure 
relationships in genetically determined PD and iPD.  
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